Waiv

Paris, France · Privately Held (backing)

Developer of artificial intelligence-based diagnostic tests designed to support precision oncology and biomarker-driven medicine. Waiv is based in Paris, France. Its last reported valuation was $499 million in Mar 2026. It has raised $32.9 million.

Last reported valuation
$499.1M
Oct 2026
Priced at
—
Total raised
$32.9M
Last round
—

Who backs Waiv?

5 investors
InvestorType
SerenaVenture capital
OTB Ventures—
Alpha Intelligence Capital—
Karista (Paris)—
SISTAFUND—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Waiv investors

5 investors are on record for Waiv, including Serena, OTB Ventures, Alpha Intelligence Capital and Karista (Paris).

Free account
More of Waiv with a free account
  • ·Watch Waiv: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Waiv. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View